{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:49:45Z","timestamp":1782276585645,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Malaria is a fatal disease affecting millions of people worldwide, primarily\ndue to infection by Plasmodium falciparum. The emergence of multidrug-resistant parasite strains\nhas necessitated the exploration of novel therapeutic targets. Plasmodium falciparum DNA gyrase A\n(pfDNA gyrase A), an essential topoisomerase II that is not present in humans, is a promising antimalarial drug target. This study explores the inhibitory potential of three Withania somnifera withanolide derivatives, D, E, and O, against pfDNA gyrase A<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An integrated structure-based computational analysis was conducted to explore the inhibitory potential of three withanolides (D, E, and O) against pfDNA gyrase A. Molecular docking, Molecular Dynamics (MD) simulations, and Molecular Mechanics\/Generalized Born Surface Area\n(MM\/GBSA) free energy calculations were performed. Pharmacokinetic properties were analysed\nusing SWISS ADME and pkCSM tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Molecular docking revealed high binding affinities for withanolide D (-9.14kcal\/mol),\nE (-9.73kcal\/mol), and O (-9.00kcal\/mol), with interactions mediated through key catalytic residues,\nsuch as GLU648, LYS647, and TRY590, via hydrogen bonding and hydrophobic contacts. MD simulations confirmed the structural integrity and compactness of the complexes through Root Mean\nSquare Deviation (RMSD), Root Mean Square Fluctuation (RMSF), Radius of Gyration (Rg), and\nSolvent Accessible Surface Area (SASA). MM\/GBSA calculations are further supported by showing\nthe lowest binding free energy for withanolide O and E (\u0394Gbind =-20.89 and -20.22 kcal\/mol). The\nADME studies showed favourable pharmacokinetic and physicochemical properties<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This study identifies pfDNA gyrase A as a potential molecular target of Withania somnifera-derived withanolides and elucidates their inhibitory mechanism. Withanolides O and E exhibited strong binding affinity, favorable energetics, and distinct dynamic effects, acting through activesite occlusion and allosteric modulation, respectively. Molecular dynamics and free-energy analyses\nsuggest that effective inhibition results from both structural stabilization and the disruption of critical\nenzyme motions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Withanolide derivatives were identified as promising inhibitors of pfDNA gyrase A,\nhighlighting their potential as antimalarial agents for addressing drug-resistant malaria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501453689260424110443","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:44:22Z","timestamp":1782276262000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic Insights into the Inhibition of Plasmodium falciparum DNA\nGyrase A by Withanolide Derivatives through Integrated Computational\nAnalysis"],"prefix":"10.2174","volume":"27","author":[{"given":"Bini Chhetri","family":"Soren","sequence":"first","affiliation":[{"name":"Department of Research and Development, Quanton BioLife Sciences, Ghatsila, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soujanya J.","family":"Vastrad","sequence":"additional","affiliation":[{"name":"Department ofPharmacy Practice, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, New BEL Road, M.S.R. Nagar,Bengaluru, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Junied","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Quanton BioLife Sciences, Ghatsila, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Srikanth","sequence":"additional","affiliation":[{"name":"Department of Biosciences, University of Milan, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Chimalamari","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice,Faculty of Clinical Pharmacy, SAC College of Pharmacy, BG Nagara, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BJ","family":"Mahender Kumar Jayappa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice,Faculty of Clinical Pharmacy, SAC College of Pharmacy, BG Nagara, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-1725","authenticated-orcid":true,"given":"Jagadish Babu","family":"Dasari","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Quanton BioLife Sciences, Ghatsila, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501453689260424110443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255483\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501453689260424110443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:45:41Z","timestamp":1782276341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255483\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501453689260424110443","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}